As a result, the SOX2OT-miR-122-SOX3-TDGF-1 pathway establishes a positive feedback loop and governs the biological activities of GSCs; this knowledge may lead to a new approach to treating gliomas [94]. The gene discussed is SOX3; the disease is central nervous system cancer.